Kamada Ltd SEC filings KMDA
Kamada Ltd has 538 filings in SEC EDGAR's recent list, going back to Jan 24, 2013. Its latest annual report, Form 20-F, was filed on Mar 11, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Sep 15, 2026 | — |
| EFFECT | Filing | Sep 14, 2023 | — |
| CORRESP | Letter to the SEC | Sep 13, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 2, 2019 | — |
| CORRESP | Letter to the SEC | Jul 18, 2019 | — |
| UPLOAD | Letter from the SEC | Jul 8, 2019 | — |
| CT ORDER | Filing | Mar 19, 2019 | — |
| EFFECT | Filing | Jul 13, 2017 | — |
| CORRESP | Letter to the SEC | Jul 13, 2017 | — |
| CORRESP | Letter to the SEC | Jul 12, 2017 | — |
| CT ORDER | Filing | Apr 14, 2017 | — |
| UPLOAD | Letter from the SEC | Dec 2, 2016 | — |
| CT ORDER | Filing | Apr 4, 2016 | — |
| CT ORDER | Filing | May 13, 2015 | — |
| EFFECT | Filing | May 30, 2013 | — |
| CT ORDER | Filing | May 30, 2013 | — |
| CORRESP | Letter to the SEC | May 28, 2013 | — |
| CORRESP | Letter to the SEC | May 28, 2013 | — |
| 8-A12B | Form 8-a12b | May 28, 2013 | — |
| CORRESP | Letter to the SEC | May 22, 2013 | — |
| UPLOAD | Letter from the SEC | May 20, 2013 | — |
| CORRESP | Letter to the SEC | May 15, 2013 | — |
| UPLOAD | Letter from the SEC | Apr 19, 2013 | — |
| CORRESP | Letter to the SEC | Apr 11, 2013 | — |
| DRS/A | Filing | Mar 25, 2013 | — |
| UPLOAD | Letter from the SEC | Mar 21, 2013 | — |
| DRSLTR | Filing | Mar 8, 2013 | — |
| DRS/A | Filing | Mar 8, 2013 | — |
| UPLOAD | Letter from the SEC | Feb 21, 2013 | — |
| DRS | Filing | Jan 24, 2013 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KMDA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Rehovot, Israel
- SEC filer status
- Accelerated filer
- SEC CIK
- 1567529
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.